• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定出一种β-内酰胺酶抑制蛋白变体,它是金黄色葡萄球菌 PC1β-内酰胺酶的有效抑制剂。

Identification of a β-lactamase inhibitory protein variant that is a potent inhibitor of Staphylococcus PC1 β-lactamase.

机构信息

Department of Pharmacology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA.

出版信息

J Mol Biol. 2011 Mar 11;406(5):730-44. doi: 10.1016/j.jmb.2011.01.014. Epub 2011 Jan 13.

DOI:10.1016/j.jmb.2011.01.014
PMID:21238457
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3081586/
Abstract

β-Lactamase inhibitory protein (BLIP) binds and inhibits a diverse collection of class A β-lactamases. Widespread resistance to β-lactam antibiotics currently limits the treatment strategies for Staphylococcus infections. The goals of this study were to determine the binding affinity of BLIP for Staphylococcus aureus PC1 β-lactamase and to identify mutants that alter binding affinity. The BLIP inhibition constant (K(i)) for PC1 β-lactamase was measured at 350 nM, and isothermal titration calorimetry experiments indicated a binding constant (K(d)) of 380 nM. Twenty-three residue positions in BLIP that contact β-lactamase were randomized, and phage display was used to sort the libraries for tight binders to immobilized PC1 β-lactamase. The BLIP(K74G) mutant was the dominant clone selected, and it was found to inhibit the PC1 β-lactamase with a K(i) of 42 nM, while calorimetry indicated a K(d) of 26 nM. Molecular modeling studies suggested that BLIP binds weakly to the PC1 β-lactamase due to the presence of alanine at position 104 of PC1. This position is occupied by glutamate in the TEM-1 enzyme, where it forms a salt bridge with the BLIP residue Lys74 that is important for the stability of the complex. This hypothesis was confirmed by showing that the PC1(A104E) enzyme binds BLIP with 15-fold greater affinity than wild-type PC1 β-lactamase. Kinetic measurements indicated similar association rates for all complexes with variation in affinity due to altered dissociation rate constants, suggesting that changes in short-range interactions are responsible for the altered binding properties of the mutants.

摘要

β-内酰胺酶抑制蛋白(BLIP)结合并抑制多种 A 类β-内酰胺酶。目前,β-内酰胺类抗生素的广泛耐药性限制了金黄色葡萄球菌感染的治疗策略。本研究的目的是确定 BLIP 与金黄色葡萄球菌 PC1 内酰胺酶的结合亲和力,并鉴定改变结合亲和力的突变体。测定了 BLIP 对 PC1 内酰胺酶的抑制常数(K(i))为 350 nM,等温滴定量热法实验表明结合常数(K(d))为 380 nM。BLIP 与β-内酰胺酶接触的 23 个残基位置被随机化,并用噬菌体展示技术对文库进行分拣,以获得与固定化 PC1 内酰胺酶紧密结合的紧密结合物。BLIP(K74G)突变体是选择的优势克隆,发现其对 PC1 内酰胺酶的抑制常数(K(i))为 42 nM,而量热法表明 K(d)为 26 nM。分子建模研究表明,由于 PC1 中的 104 位为丙氨酸,BLIP 与 PC1 内酰胺酶的结合较弱。该位置在 TEM-1 酶中被谷氨酸占据,它与 BLIP 残基 Lys74 形成盐桥,这对于复合物的稳定性很重要。通过证明 PC1(A104E)酶与 BLIP 的结合亲和力比野生型 PC1 内酰胺酶高 15 倍,证实了这一假设。动力学测量表明,所有复合物的结合速率相似,亲和力的变化是由于解离速率常数的改变,这表明短程相互作用的变化是导致突变体结合特性改变的原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9530/3081586/41024fd8ad3f/nihms274863f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9530/3081586/9fa6720f821d/nihms274863f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9530/3081586/1fc0951bd3f5/nihms274863f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9530/3081586/6ffdb35e4856/nihms274863f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9530/3081586/6f9e03dbbf03/nihms274863f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9530/3081586/2e6881696e53/nihms274863f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9530/3081586/1a2a2fb2db19/nihms274863f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9530/3081586/41024fd8ad3f/nihms274863f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9530/3081586/9fa6720f821d/nihms274863f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9530/3081586/1fc0951bd3f5/nihms274863f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9530/3081586/6ffdb35e4856/nihms274863f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9530/3081586/6f9e03dbbf03/nihms274863f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9530/3081586/2e6881696e53/nihms274863f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9530/3081586/1a2a2fb2db19/nihms274863f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9530/3081586/41024fd8ad3f/nihms274863f7.jpg

相似文献

1
Identification of a β-lactamase inhibitory protein variant that is a potent inhibitor of Staphylococcus PC1 β-lactamase.鉴定出一种β-内酰胺酶抑制蛋白变体,它是金黄色葡萄球菌 PC1β-内酰胺酶的有效抑制剂。
J Mol Biol. 2011 Mar 11;406(5):730-44. doi: 10.1016/j.jmb.2011.01.014. Epub 2011 Jan 13.
2
Fine mapping of the sequence requirements for binding of beta-lactamase inhibitory protein (BLIP) to TEM-1 beta-lactamase using a genetic screen for BLIP function.利用针对β-内酰胺酶抑制蛋白(BLIP)功能的遗传筛选,对BLIP与TEM-1β-内酰胺酶结合的序列要求进行精细定位。
J Mol Biol. 2009 Jun 5;389(2):401-12. doi: 10.1016/j.jmb.2009.04.028. Epub 2009 Apr 21.
3
Interdomain flexibility and interfacial integrity of β-lactamase inhibitory protein (BLIP) modulate its binding to class A β-lactamases.β-内酰胺酶抑制蛋白(BLIP)的结构域间灵活性和界面完整性调节其与A类β-内酰胺酶的结合。
J Biol Chem. 2021 Aug;297(2):100980. doi: 10.1016/j.jbc.2021.100980. Epub 2021 Jul 21.
4
Engineering Specificity from Broad to Narrow: Design of a β-Lactamase Inhibitory Protein (BLIP) Variant That Exclusively Binds and Detects KPC β-Lactamase.从宽泛到精准的工程设计:一种专门结合并检测KPCβ-内酰胺酶的β-内酰胺酶抑制蛋白(BLIP)变体的设计
ACS Infect Dis. 2016 Dec 9;2(12):969-979. doi: 10.1021/acsinfecdis.6b00160. Epub 2016 Oct 26.
5
Analysis of the binding forces driving the tight interactions between beta-lactamase inhibitory protein-II (BLIP-II) and class A beta-lactamases.β-内酰胺酶抑制蛋白-II(BLIP-II)与 A 类β-内酰胺酶之间紧密相互作用的结合力分析。
J Biol Chem. 2011 Sep 16;286(37):32723-35. doi: 10.1074/jbc.M111.265058. Epub 2011 Jul 20.
6
Thermodynamic investigation of the role of contact residues of beta-lactamase-inhibitory protein for binding to TEM-1 beta-lactamase.β-内酰胺酶抑制蛋白的接触残基与TEM-1β-内酰胺酶结合作用的热力学研究
J Biol Chem. 2007 Jun 15;282(24):17676-84. doi: 10.1074/jbc.M611548200. Epub 2007 Apr 12.
7
Contributions of aspartate 49 and phenylalanine 142 residues of a tight binding inhibitory protein of beta-lactamases.β-内酰胺酶紧密结合抑制蛋白中天冬氨酸49和苯丙氨酸142残基的作用
J Biol Chem. 1999 Jan 22;274(4):2394-400. doi: 10.1074/jbc.274.4.2394.
8
Design of potent beta-lactamase inhibitors by phage display of beta-lactamase inhibitory protein.通过β-内酰胺酶抑制蛋白的噬菌体展示设计强效β-内酰胺酶抑制剂。
J Biol Chem. 2000 May 19;275(20):14964-8. doi: 10.1074/jbc.M001285200.
9
Identification and characterization of beta-lactamase inhibitor protein-II (BLIP-II) interactions with beta-lactamases using phage display.利用噬菌体展示技术鉴定和描述β-内酰胺酶抑制剂蛋白-II(BLIP-II)与β-内酰胺酶的相互作用。
Protein Eng Des Sel. 2010 Jun;23(6):469-78. doi: 10.1093/protein/gzq017. Epub 2010 Mar 22.
10
Binding properties of a peptide derived from beta-lactamase inhibitory protein.源自β-内酰胺酶抑制蛋白的一种肽的结合特性
Antimicrob Agents Chemother. 2001 Dec;45(12):3279-86. doi: 10.1128/AAC.45.12.3279-3286.2001.

引用本文的文献

1
Phage Display-Derived Peptides and Antibodies for Bacterial Infectious Diseases Therapy and Diagnosis.噬菌体展示技术衍生的肽和抗体在细菌性传染病治疗和诊断中的应用。
Molecules. 2023 Mar 14;28(6):2621. doi: 10.3390/molecules28062621.
2
An active site loop toggles between conformations to control antibiotic hydrolysis and inhibition potency for CTX-M β-lactamase drug-resistance enzymes.活性位点环在构象之间来回切换,以控制 CTX-M 型β-内酰胺酶耐药酶的抗生素水解和抑制效力。
Nat Commun. 2022 Nov 7;13(1):6726. doi: 10.1038/s41467-022-34564-3.
3
Tackling the Antibiotic Resistance Caused by Class A -Lactamases through the Use of -Lactamase Inhibitory Protein.通过使用β-内酰胺酶抑制蛋白来解决由 A 类β-内酰胺酶引起的抗生素耐药性。
Int J Mol Sci. 2018 Jul 30;19(8):2222. doi: 10.3390/ijms19082222.
4
Efficient production of secretory Streptomyces clavuligerus β-lactamase inhibitory protein (BLIP) in Pichia pastoris.在毕赤酵母中高效生产分泌型棒状链霉菌β-内酰胺酶抑制蛋白(BLIP)。
AMB Express. 2018 Apr 20;8(1):64. doi: 10.1186/s13568-018-0586-3.
5
Engineering Specificity from Broad to Narrow: Design of a β-Lactamase Inhibitory Protein (BLIP) Variant That Exclusively Binds and Detects KPC β-Lactamase.从宽泛到精准的工程设计:一种专门结合并检测KPCβ-内酰胺酶的β-内酰胺酶抑制蛋白(BLIP)变体的设计
ACS Infect Dis. 2016 Dec 9;2(12):969-979. doi: 10.1021/acsinfecdis.6b00160. Epub 2016 Oct 26.
6
Antibiotic adjuvants: diverse strategies for controlling drug-resistant pathogens.抗生素佐剂:控制耐药病原体的多种策略。
Chem Biol Drug Des. 2015 Jan;85(1):56-78. doi: 10.1111/cbdd.12478.
7
Controlling resistant bacteria with a novel class of β-lactamase inhibitor peptides: from rational design to in vivo analyses.用新型β-内酰胺酶抑制肽控制耐药菌:从合理设计到体内分析
Sci Rep. 2014 Aug 11;4:6015. doi: 10.1038/srep06015.
8
The intrinsic resistome of bacterial pathogens.细菌病原体的固有耐药组。
Front Microbiol. 2013 Apr 30;4:103. doi: 10.3389/fmicb.2013.00103. eCollection 2013.
9
Identification of the β-lactamase inhibitor protein-II (BLIP-II) interface residues essential for binding affinity and specificity for class A β-lactamases.鉴定β-内酰胺酶抑制剂蛋白-II(BLIP-II)与 A 类β-内酰胺酶结合亲和力和特异性所必需的界面残基。
J Biol Chem. 2013 Jun 14;288(24):17156-66. doi: 10.1074/jbc.M113.463521. Epub 2013 Apr 27.
10
Development of anti-infectives using phage display: biological agents against bacteria, viruses, and parasites.利用噬菌体展示技术开发抗感染药物:针对细菌、病毒和寄生虫的生物制剂。
Antimicrob Agents Chemother. 2012 Sep;56(9):4569-82. doi: 10.1128/AAC.00567-12. Epub 2012 Jun 4.

本文引用的文献

1
Fine mapping of the sequence requirements for binding of beta-lactamase inhibitory protein (BLIP) to TEM-1 beta-lactamase using a genetic screen for BLIP function.利用针对β-内酰胺酶抑制蛋白(BLIP)功能的遗传筛选,对BLIP与TEM-1β-内酰胺酶结合的序列要求进行精细定位。
J Mol Biol. 2009 Jun 5;389(2):401-12. doi: 10.1016/j.jmb.2009.04.028. Epub 2009 Apr 21.
2
Antibiotic-resistant bugs in the 21st century--a clinical super-challenge.21世纪的抗生素耐药性细菌——一项临床超级挑战。
N Engl J Med. 2009 Jan 29;360(5):439-43. doi: 10.1056/NEJMp0804651.
3
Structural insight into the kinetics and DeltaCp of interactions between TEM-1 beta-lactamase and beta-lactamase inhibitory protein (BLIP).对TEM-1β-内酰胺酶与β-内酰胺酶抑制蛋白(BLIP)之间相互作用的动力学和等压热容变化的结构洞察。
J Biol Chem. 2009 Jan 2;284(1):595-609. doi: 10.1074/jbc.M804089200. Epub 2008 Oct 7.
4
Computational redesign of the SHV-1 beta-lactamase/beta-lactamase inhibitor protein interface.SHV-1β-内酰胺酶/β-内酰胺酶抑制剂蛋白界面的计算重新设计。
J Mol Biol. 2008 Oct 24;382(5):1265-75. doi: 10.1016/j.jmb.2008.05.051. Epub 2008 May 29.
5
Thermodynamic investigation of the role of contact residues of beta-lactamase-inhibitory protein for binding to TEM-1 beta-lactamase.β-内酰胺酶抑制蛋白的接触残基与TEM-1β-内酰胺酶结合作用的热力学研究
J Biol Chem. 2007 Jun 15;282(24):17676-84. doi: 10.1074/jbc.M611548200. Epub 2007 Apr 12.
6
The molecular evolution of methicillin-resistant Staphylococcus aureus.耐甲氧西林金黄色葡萄球菌的分子进化
Clin Microbiol Infect. 2007 Mar;13(3):222-35. doi: 10.1111/j.1469-0691.2006.01573.x.
7
Binding hot spots in the TEM1-BLIP interface in light of its modular architecture.鉴于TEM1-BLIP界面的模块化结构,其结合热点。
J Mol Biol. 2007 Jan 19;365(3):663-79. doi: 10.1016/j.jmb.2006.09.076. Epub 2006 Oct 3.
8
Structural and computational characterization of the SHV-1 beta-lactamase-beta-lactamase inhibitor protein interface.SHV-1β-内酰胺酶-β-内酰胺酶抑制剂蛋白界面的结构与计算表征
J Biol Chem. 2006 Sep 8;281(36):26745-53. doi: 10.1074/jbc.M603878200. Epub 2006 Jun 29.
9
Diversity and evolution of blaZ from Staphylococcus aureus and coagulase-negative staphylococci.金黄色葡萄球菌和凝固酶阴性葡萄球菌中blaZ基因的多样性与进化
J Antimicrob Chemother. 2006 Mar;57(3):450-60. doi: 10.1093/jac/dki492. Epub 2006 Jan 31.
10
Beta-lactam resistance in Staphylococcus aureus: the adaptive resistance of a plastic genome.金黄色葡萄球菌中的β-内酰胺耐药性:可塑性基因组的适应性耐药
Cell Mol Life Sci. 2005 Nov;62(22):2617-33. doi: 10.1007/s00018-005-5148-6.